Please see article and (two great videos!) on Sorrento Therapeutics (OTC:SRNE) at my new site MicrocapResearch.com
Gary
Sorrento Therapeutics (SRNE) Could Be THE Most Disruptive Company In Cancer R&D
Analyst's Disclosure: The author is long SRNE.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.